Trial · NCT00938314
Results by group56
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 56
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| National Institutes of Health Stroke Scale (NIHSS) Change From Baseline at Day 90 | NTx®-265 Low Dose | 6.79 | Standard Deviation 4.22 | scores on a scale | |
| National Institutes of Health Stroke Scale (NIHSS) Change From Baseline at Day 90 | NTx®-265 Medium Dose | 6.50 | Standard Deviation 4.53 | scores on a scale | |
| National Institutes of Health Stroke Scale (NIHSS) Change From Baseline at Day 90 | NTx®-265 High Dose | 6.08 | Standard Deviation 3.30 | scores on a scale | |
| National Institutes of Health Stroke Scale (NIHSS) Change From Baseline at Day 90 | Saline Placebo | 7.17 | Standard Deviation 4.24 | scores on a scale | |
| NIHSS Response >=4 at Day 90 | NTx®-265 Low Dose | No Response (<4) | 6 | participants | |
| NIHSS Response >=4 at Day 90 | NTx®-265 Medium Dose | No Response (<4) | 7 | participants | |
| NIHSS Response >=4 at Day 90 | NTx®-265 High Dose | No Response (<4) | 5 | participants | |
| NIHSS Response >=4 at Day 90 | Saline Placebo | No Response (<4) | 5 | participants | |
| NIHSS Response >=4 at Day 90 | NTx®-265 Low Dose | Response (>=4) | 18 | participants | |
| NIHSS Response >=4 at Day 90 | NTx®-265 Medium Dose | Response (>=4) | 17 | participants | |
| NIHSS Response >=4 at Day 90 | NTx®-265 High Dose | Response (>=4) | 19 | participants | |
| NIHSS Response >=4 at Day 90 | Saline Placebo | Response (>=4) | 19 | participants | |
| NIHSS Change From Baseline at Day 30 | NTx®-265 Low Dose | 4.67 | Standard Deviation 4.53 | scores on a scale | |
| NIHSS Change From Baseline at Day 30 | NTx®-265 Medium Dose | 4.29 | Standard Deviation 3.37 | scores on a scale | |
| NIHSS Change From Baseline at Day 30 | NTx®-265 High Dose | 5.00 | Standard Deviation 2.98 | scores on a scale | |
| NIHSS Change From Baseline at Day 30 | Saline Placebo | 5.33 | Standard Deviation 3.33 | scores on a scale | |
| Modified Rankin Scale (mRS) Response <=2 at Day 90 | NTx®-265 Low Dose | response (mRS <=2) | 11 | participants | |
| Modified Rankin Scale (mRS) Response <=2 at Day 90 | NTx®-265 Medium Dose | response (mRS <=2) | 11 | participants | |
| Modified Rankin Scale (mRS) Response <=2 at Day 90 | NTx®-265 High Dose | response (mRS <=2) | 15 | participants | |
| Modified Rankin Scale (mRS) Response <=2 at Day 90 | Saline Placebo | response (mRS <=2) | 18 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00938314/results